Management of Acute and Chronic Pain: Request for Comment, 21441-21442 [2020-08127]
Download as PDF
<![CDATA[
21441
Federal Register / Vol. 85, No. 75 / Friday, April 17, 2020 / Notices
NHAMCS provides a range of baseline
data on the characteristics of the users
and providers of hospital ambulatory
medical care. Data collected include
patients’ demographic characteristics,
reason(s) for visit, providers’ diagnoses,
diagnostic services, medications, and
disposition. These data, together with
trend data, may be used to monitor the
effects of change in the health care
system, for the planning of health
services, improving medical education,
determining health care work force
needs, and assessing the health status of
the population.
Starting 2018, NHAMCS was
modified to assess only hospital
emergency departments. The survey
components that assessed hospital
outpatient departments and ambulatory
surgery locations were discontinued.
Users of NHAMCS data include, but are
not limited to, congressional offices,
Federal agencies, state and local
governments, schools of public health,
colleges and universities, private
industry, nonprofit foundations,
professional associations, clinicians,
researchers, administrators, and health
planners.
The burden is to complete the 2020
data collection which is currently
underway and collect data over the
following three years (2021–2023)
without change to the current survey
activities. However, starting with 2021
data collection, the Assurance of
Confidentiality statement will be
updated to the new citation for the
Confidential Information Protection and
Statistical Efficiency Act (CIPSEA)
language. There are no costs to the
respondents other than their time. The
total estimated annualized burden hours
are 1,500. The adjusted increase of 712
burden hours is due to the new method
of calculating burden to include all
sampled hospitals.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Hospital Chief Executive Officer .....................
Ancillary Service Executive .............................
Medical Record Clerk .....................................
Ancillary Service Executive .............................
Hospital Induction Data Collection .................
Ambulatory Unit Induction Data Collection ....
Retrieving Patient Records ............................
Telephone Reinterview ..................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–08166 Filed 4–16–20; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0029]
Management of Acute and Chronic
Pain: Request for Comment
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for comment.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the opening
of a docket to obtain comment
concerning perspectives on and
experiences with pain and pain
management, including but not limited
to the benefits and harms of opioid use,
from patients with acute or chronic
pain, patients’ family members and/or
caregivers, and health care providers
who care for patients with pain or
conditions that can complicate pain
management (e.g., opioid use disorder
or overdose)—hereafter called
SUMMARY:
VerDate Sep<11>2014
18:19 Apr 16, 2020
‘‘stakeholders.’’ CDC will use these
comments to inform its understanding
of stakeholders’ values and preferences
related to pain and pain management
options.
Written comments must be
received on or before June 16, 2020.
ADDRESSES: Submit written comments,
identified by Docket No. CDC–2020–
0029 by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Shannon Lee, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop S106–9,
Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Shannon Lee, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop S106–9, Atlanta,
Georgia 30329, 404–498–3290,
InjuryCenterEngage@cdc.gov.
SUPPLEMENTARY INFORMATION:
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondent
Jkt 250001
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
547
1,093
547
167
Number of
responses per
respondent
1
1
100
1
Average
burden per
response
(in hours)
30/60
15/60
1/60
15/60
data related to perspectives on and
experiences with pain and pain
management. CDC invites comments
specifically on topics focused on using
or prescribing opioid pain medications,
non-opioid medications, or nonpharmacological treatments (e.g.,
exercise therapy or cognitive behavioral
therapy). These topics are as follows:
• Experiences managing pain, which
might include the benefits, risks, and/or
harms of the pain management options
listed above.
• Experiences choosing among the
pain management options listed above,
including considering factors such as
each option’s accessibility, cost,
benefits, and/or risks.
• Experiences getting information
needed to make pain management
decisions.
Please note that comments received,
including attachments and other
supporting materials, are part of the
public record and are subject to public
disclosure. Comments will be posted on
https://www.regulations.gov. Therefore,
do not include any information in your
comment or supporting materials that
you consider confidential, proprietary,
or inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
E:\FR\FM\17APN1.SGM
17APN1
21442
Federal Register / Vol. 85, No. 75 / Friday, April 17, 2020 / Notices
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign. CDC will carefully
consider all comments submitted.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Background
[30Day–20–0607]
Public comment will help CDC’s
understanding of stakeholders’ values
and preferences regarding pain
management and will complement
CDC’s ongoing work assessing the need
for updating or expanding the CDC
Guideline for Prescribing Opioids for
Chronic Pain, published in 2016
(available in the Supporting Materials
tab of the docket and at: https://
www.cdc.gov/mmwr/volumes/65/rr/
rr6501e1.htm). Please note that HHS/
CDC is also planning opportunities for
stakeholder engagements and
conversations on these topics. These
have been postponed because of
COVID–19 but will be announced in a
future Federal Register Notice when
they are rescheduled.
More information about CDC’s
assessment of the need for updating or
expanding the Guideline and the
establishment of a federal advisory
committee workgroup to provide expert
input and observations to CDC on the
possible Guideline update or expansion
is available at https://www.cdc.gov/
injury/bsc/opioid-workgroup-2019.html.
If the Guideline is updated or expanded,
CDC would request public comment on
the draft document through a notice in
the Federal Register prior to final
publication.
Anyone who would like to receive
information related to CDC’s ongoing
work specific to drug overdose
prevention (including the ongoing
response to the opioid overdose
epidemic) as well as other updates (e.g.,
pertaining to resources and tools) may
sign up at www.cdc.gov/emailupdates
and select topics of interest. Available
offerings include:
Agency Forms Undergoing Paperwork
Reduction Act Review
• Subscription Topics: Injury, Violence
& Safety
• Subtopic: Drug Overdose News
jbell on DSKJLSW7X2PROD with NOTICES
Dated: April 14, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2020–08127 Filed 4–16–20; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
18:19 Apr 16, 2020
Jkt 250001
Centers for Disease Control and
Prevention
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘The National
Violent Death Reporting System
(NVDRS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on October
22, 2019 to obtain comments from the
public and affected agencies. CDC
received two anonymous nonsubstantive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
The National Violent Death Reporting
System (NVDRS) (OMB Control No.
0920–0607, Exp. 11/30/2020)—Revision
— National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Violence is a public health problem.
The World Health Organization has
estimated that 804,000 suicides and
475,000 homicides occurred in the year
2012 worldwide. Violence in the United
States is a particular problem for the
young; suicide and homicide were
among the top four leading causes of
death for Americans 10–34 and 1–34
years of age in 2015, respectively. In
2002 Congress approved the first
appropriation to start the National
Violent Death Reporting System
(NVDRS). NVDRS is coordinated and
funded at the federal level but is
dependent on separate data collection
efforts managed by the state health
department (or their bona fide agent) in
each state.
NVDRS, implemented by the Centers
for Disease Control and Prevention
(CDC), is a state-based surveillance
system developed to monitor the
occurrence of violent deaths (i.e.,
homicide, suicide, undetermined
deaths, and unintentional firearm
deaths) in the United States (U.S.) by
collecting comprehensive, detailed,
useful, and timely data from multiple
sources (e.g., death certificates, coroner/
medical examiner reports, law
enforcement reports) into a useable,
anonymous database. NVDRS is an
ongoing surveillance system that
captures annual violent death counts
and circumstances that precipitate each
violent incident. Data on violent death
is defined as a death resulting from the
intentional use of physical force or
power (e.g., threats or intimidation)
against oneself, another person, or
against a group or community. CDC
aggregates de-identified data from each
state into one large national database
that is analyzed and released in annual
reports and publications. Descriptive
analyses such as frequencies and rates
are employed. A restricted access
E:\FR\FM\17APN1.SGM
17APN1
]]>Agencies
[Federal Register Volume 85, Number 75 (Friday, April 17, 2020)]
[Notices]
[Pages 21441-21442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08127]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0029]
Management of Acute and Chronic Pain: Request for Comment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for comment.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) in the
Department of Health and Human Services (HHS) announces the opening of
a docket to obtain comment concerning perspectives on and experiences
with pain and pain management, including but not limited to the
benefits and harms of opioid use, from patients with acute or chronic
pain, patients' family members and/or caregivers, and health care
providers who care for patients with pain or conditions that can
complicate pain management (e.g., opioid use disorder or overdose)--
hereafter called ``stakeholders.'' CDC will use these comments to
inform its understanding of stakeholders' values and preferences
related to pain and pain management options.
DATES: Written comments must be received on or before June 16, 2020.
ADDRESSES: Submit written comments, identified by Docket No. CDC-2020-
0029 by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Shannon Lee, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop S106-9, Atlanta, Georgia
30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to https://regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Shannon Lee, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop S106-9, Atlanta,
Georgia 30329, 404-498-3290, [email protected].
SUPPLEMENTARY INFORMATION:
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data related to
perspectives on and experiences with pain and pain management. CDC
invites comments specifically on topics focused on using or prescribing
opioid pain medications, non-opioid medications, or non-pharmacological
treatments (e.g., exercise therapy or cognitive behavioral therapy).
These topics are as follows:
Experiences managing pain, which might include the
benefits, risks, and/or harms of the pain management options listed
above.
Experiences choosing among the pain management options
listed above, including considering factors such as each option's
accessibility, cost, benefits, and/or risks.
Experiences getting information needed to make pain
management decisions.
Please note that comments received, including attachments and other
supporting materials, are part of the public record and are subject to
public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your
comment or supporting materials that you consider confidential,
proprietary, or inappropriate for public disclosure. If you include
your name, contact information, or other information that identifies
you in the body of your comments, that information will be on public
display. CDC will review all submissions and may choose to redact, or
withhold, submissions containing private or proprietary information
such
[[Page 21442]]
as Social Security numbers, medical information, inappropriate
language, or duplicate/near duplicate examples of a mass-mail campaign.
CDC will carefully consider all comments submitted.
Background
Public comment will help CDC's understanding of stakeholders'
values and preferences regarding pain management and will complement
CDC's ongoing work assessing the need for updating or expanding the CDC
Guideline for Prescribing Opioids for Chronic Pain, published in 2016
(available in the Supporting Materials tab of the docket and at:
https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm). Please note that
HHS/CDC is also planning opportunities for stakeholder engagements and
conversations on these topics. These have been postponed because of
COVID-19 but will be announced in a future Federal Register Notice when
they are rescheduled.
More information about CDC's assessment of the need for updating or
expanding the Guideline and the establishment of a federal advisory
committee workgroup to provide expert input and observations to CDC on
the possible Guideline update or expansion is available at https://www.cdc.gov/injury/bsc/opioid-workgroup-2019.html. If the Guideline is
updated or expanded, CDC would request public comment on the draft
document through a notice in the Federal Register prior to final
publication.
Anyone who would like to receive information related to CDC's
ongoing work specific to drug overdose prevention (including the
ongoing response to the opioid overdose epidemic) as well as other
updates (e.g., pertaining to resources and tools) may sign up at
www.cdc.gov/emailupdates and select topics of interest. Available
offerings include:
Subscription Topics: Injury, Violence & Safety
Subtopic: Drug Overdose News
Dated: April 14, 2020.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2020-08127 Filed 4-16-20; 8:45 am]
BILLING CODE 4163-18-P
